Stockscreener 앱 받기
71.93
2.63%
-1.94
시간 외 거래:
71.93
전일 마감가:
$73.87
열려 있는:
$73.75
하루 거래량:
1.38M
Relative Volume:
1.48
시가총액:
$4.76B
수익:
순이익/손실:
$-116.25M
주가수익비율:
-30.08
EPS:
-2.3912
순현금흐름:
$-91.19M
1주 성능:
-12.40%
1개월 성능:
-23.11%
6개월 성능:
+7.25%
1년 성능:
+170.82%
1일 변동 폭
$70.50
$74.26
1주일 범위
$70.50
$82.95
52주 변동 폭
$25.11
$115.52
Oruka Therapeutics Inc Stock (ORKA) Company Profile
명칭
Oruka Therapeutics Inc
전화
650-606-7910
주소
855 OAK GROVE AVE., MENLO PARK
Compare ORKA vs VRTX, MRNA, REGN, ARGX, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ORKA
Oruka Therapeutics Inc
|
71.93 | 4.76B | 0 | -116.25M | -91.19M | -2.3912 |
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Oruka Therapeutics Inc Stock (ORKA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-18 | 개시 | Piper Sandler | Overweight |
| 2025-11-13 | 개시 | Jefferies | Buy |
| 2025-10-27 | 개시 | Guggenheim | Buy |
| 2025-10-13 | 개시 | Barclays | Overweight |
| 2025-05-22 | 개시 | BTIG Research | Buy |
| 2025-02-04 | 개시 | Wolfe Research | Outperform |
| 2024-10-11 | 개시 | Stifel | Buy |
| 2024-10-07 | 개시 | H.C. Wainwright | Buy |
| 2024-09-17 | 개시 | Leerink Partners | Outperform |
| 2024-09-16 | 개시 | TD Cowen | Buy |
| 2024-09-13 | 개시 | Jefferies | Buy |
| 2018-02-27 | 개시 | Ascendiant Capital Markets | Buy |
| 2013-10-09 | 개시 | Dawson James | Buy |
모두보기
Oruka Therapeutics Inc 주식(ORKA)의 최신 뉴스
These 2 Stocks Have Run Circles Around the Magnificent Seven This Year, and Wall Street Says There Is More Upside Ahead - The Motley Fool
Oruka Therapeutics senior vice president Arjun Agarwal sells $805,888 in stock - Investing.com
Form 4 Oruka Therapeutics Inc: Arjun Agarwal (Senior Vice President, Finance) For: 12 October - Investing.com India
Form 4 Oruka Therapeutics Inc: Arjun Agarwal (Senior Vice President, Finance) For: 12 October - Investing.com UK
Oruka Therapeutics' Arjun Agarwal Executes Option Exercises and Sells Nearly 10,000 Shares - Kalkine Media
An officer proposes selling 9,999 Oruka Therapeutics (ORKA) shares acquired through stock options. - Stock Titan
Form 4 Oruka Therapeutics Inc For: 2 October By Investing.com - Investing.com South Africa
Oruka Therapeutics (ORKA) CEO Lawrence Klein Sells 25,000 Shares - GuruFocus
Oruka Therapeutics CEO Klein sells $2.09m in stock - Investing.com
Form 4 Oruka Therapeutics Inc For: 2 October By Investing.com - Investing.com Nigeria
25,000 shares from a stock-option exercise are proposed for sale at Oruka Therapeutics (NASDAQ: ORKA). - Stock Titan
Oruka Therapeutics Announces Positive Week 28 Data for ORKA-001 from the Ongoing EVERLAST-A Trial Showing Deepening of Responses Without Additional Dosing - GlobeNewswire Inc.
Oruka Therapeutics general counsel Paul Quinlan sells $936k in stock - Investing.com Nigeria
Form 4 Oruka Therapeutics Inc For: 22 September By Investing.com - Investing.com Nigeria
Form 4 Oruka Therapeutics Inc For: 22 September By Investing.com - Investing.com Canada
Oruka Therapeutics general counsel Paul Quinlan sells $936k in stock - Investing.com Canada
Form 4 Oruka Therapeutics Inc For: 22 September - Investing.com India
Oruka Therapeutics general counsel Paul Quinlan sells $936k in stock - Investing.com
Details on Warrant Exercise and Subsequent Share Sales by Oruka Therapeutics' General Counsel - Kalkine Media
Oruka Therapeutics SVP Arjun Agarwal Sells 533 Shares Under Rule 10b5-1 Plan - Kalkine Media
Oruka Therapeutics SVP Arjun Agarwal sells $51,034 in ORKA stock - Investing.com
Oruka Therapeutics SVP Arjun Agarwal sells $51,034 in ORKA stock By Investing.com - Investing.com South Africa
Oruka Therapeutics SVP Arjun Agarwal sells $51,034 in ORKA stock By Investing.com - Investing.com Nigeria
Oruka Therapeutics (NASDAQ: ORKA) insider plans new share sale after recent 10b5-1 trades - Stock Titan
Oruka Therapeutics SVP Agarwal sells over $926k in common stock By Investing.com - Investing.com South Africa
Oruka Therapeutics SVP Agarwal sells over $926k in common stock - Investing.com India
Oruka Therapeutics general counsel Paul Quinlan sells $99,442 in stock - Investing.com
Oruka Therapeutics CEO Lawrence Klein sells $234,680 in ORKA stock - Investing.com
Oruka Therapeutics general counsel Paul Quinlan sells $99,442 in stock By Investing.com - Investing.com Canada
Oruka Therapeutics COO Sandler sells $86,713 in common stock - Investing.com
Oruka (ORKA) legal chief sells shares to cover RSU taxes - Stock Titan
Oruka (ORKA) finance SVP sells 10K shares after option exercises - Stock Titan
Oruka Therapeutics to Attend Morgan Stanley Global Healthcare Conference - Bitget
Morgan Stanley's New York healthcare conference includes Oruka - Stock Titan
Oruka Therapeutics to Attend the 2026 Morgan Stanley Global Healthcare Conference - GlobeNewswire
About Oruka Therapeutics Inc aStock - Coinbase
H.C. Wainwright reiterates Oruka Therapeutics stock rating at buy By Investing.com - Investing.com Canada
H.C. Wainwright reiterates Oruka Therapeutics stock rating at buy - Investing.com UK
UBS Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $130 - Moomoo
Oruka Therapeutics CEO Klein sells $6.8m in stock By Investing.com - Investing.com South Africa
Oruka Therapeutics COO Laura Sandler sells $459,101 in stock By Investing.com - Investing.com South Africa
Oruka Therapeutics(ORKA.US) Officer Sells US$6.89 Million in Common Stock - Moomoo
Oruka Therapeutics COO Laura Sandler sells $459,101 in stock By Investing.com - Investing.com Nigeria
Oruka Therapeutics CEO Klein sells $6.8m in stock By Investing.com - Investing.com Nigeria
Oruka Therapeutics COO Laura Sandler sells $459,101 in stock - Investing.com
Oruka Therapeutics CEO Klein sells $6.8m in stock - Investing.com
Oruka Therapeutics COO Laura Sandler sells $459,101 in stock - Investing.com India
Oruka Therapeutics COO Laura Sandler sells $459,101 in stock By Investing.com - Investing.com Canada
Oruka Therapeutics CEO Klein sells $6.8m in stock - Investing.com UK
Insider at Oruka Therapeutics (ORKA) plans stock sale from option exercise - Stock Titan
Oruka Therapeutics Inc (ORKA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Oruka Therapeutics Inc 주식 (ORKA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Goncalves Joana | Chief Medical Officer |
Oct 15 '26 |
Sale |
74.81 |
7,000 |
523,648 |
31,771 |
| JOANA GONCALVES | Officer |
Oct 15 '26 |
Proposed Sale |
76.68 |
21,000 |
1,610,280 |
0 |
| Agarwal Arjun | Senior Vice President, Finance |
Oct 12 '26 |
Option Exercise |
15.69 |
9,999 |
156,903 |
24,218 |
| Agarwal Arjun | Senior Vice President, Finance |
Oct 12 '26 |
Sale |
80.60 |
9,999 |
805,889 |
14,219 |
| Arjun Agarwal | Officer |
Oct 12 '26 |
Proposed Sale |
82.11 |
9,999 |
821,018 |
0 |
| Klein Lawrence Otto | Chief Executive Officer |
Oct 01 '26 |
Sale |
83.62 |
25,000 |
2,090,593 |
923,128 |
| LAWRENCE KLEIN | Director |
Oct 01 '26 |
Proposed Sale |
83.29 |
25,000 |
2,082,250 |
0 |
| Klein Lawrence Otto | Chief Executive Officer |
Oct 01 '26 |
Option Exercise |
7.80 |
25,000 |
195,000 |
948,128 |
| Arjun Agarwal | Officer |
Sep 21 '26 |
Proposed Sale |
94.96 |
533 |
50,614 |
0 |
| Quinlan Paul T | General Counsel |
Sep 21 '26 |
Option Exercise |
7.80 |
10,000 |
78,000 |
39,995 |
9.95%
0.03%
자본화:
|
볼륨(24시간):